Skip to main content
. Author manuscript; available in PMC: 2023 Jul 1.
Published in final edited form as: Crit Care Med. 2022 Mar 14;50(7):1127–1137. doi: 10.1097/CCM.0000000000005535

Table 1.

Baseline characteristics of patients who required tracheal intubation, by immunocompromised status

Variable No IC diagnosis
(n=2,710)
IC, not HCT
(n=2,179)
HCT
(n=459)
p a
Age Distribution, n (%)
 1 month to 23 months 1,588 (59) 529 (24) 142 (31) <0.001
 2 years to 5 years 414 (15) 559 (26) 98 (21)
 6 years to 12 years 335 (12) 574 (26) 104 (23)
 13 years to 18 years 373 (14) 517 (24) 115 (25)
Male sex, n (%) 1,474 (54) 1,174 (54) 249 (54) 0.51
Race, n (%)
 American Indian/Alaska Native 36 (1) 24 (1) 1 (<1) <0.001
 Asian 96 (4) 120 (5) 11 (2)
 Black or African American 484 (18) 274 (13) 54 (12)
 Hawaiian or Pacific Islander 12 (<1) 3 (<1) 0 (0)
 Hispanic or Latino 353 (13) 342 (16) 49 (11)
 White 1,226 (45) 976 (45) 157 (34)
 Other/Unspecified 503 (19) 440 (20) 187 (41)
PIM-2 POD, median [IQR] 1.42 [0.85–4.84] 2.91 [0.91–4.97] 4.13 [1.05–5.68] <0.001
Admission source, n (%)
 Emergency department 1,193 (44) 556 (26) 39 (9) <0.001
 Hospital ward 1,062 (39) 1,306 (60) 392 (85)
 Operating room 244 (9) 180 (8) 16 (3)
 Other 211 (8) 137 (6) 12 (3)
Severe sepsis/septic shock, n (%) 387 (14) 456 (21) 173 (38) <0.001
Asthma diagnosis, n (%) 208 (8) 138 (6) 38 (8) 0.12
Limitations of care, n (%)b 230/2,305 (10) 249/1,933 (13) 95/402 (24) <0.001
Pre-intubation support, n (%)
 None 1,731 (64) 1,547 (70) 245 (53) <0.001
 HFNC 444 (16) 315 (15) 114 (25)
 NIPPV 535 (20) 317 (15) 100 (22)
a

Kruskal-Wallis H test for continuous variables, χ2 test for categorical variables, α = 0.05.

b

Limitations of care data was unavailable for 16% of study participants (No IC diagnosis: 19%; IC, not HCT: 14%; HCT: 13%).

IC: Immunocompromised; HCT: hematopoietic cell transplant; PIM-2: Paediatric Index of Mortality-2; IQR: Interquartile Range; HFNC: high-flow nasal cannula; NIPPV: noninvasive positive pressure ventilation.